Riverside's Decera Clinical acquires life sciences platform Onviv

What's the deal? Decera Clinical, backed by The Riverside CompanyDealroom has a profile for this one. Try Dealroom →, has acquired OnvivDealroom has a profile for this one. Try Dealroom →, a healthcare knowledge platform serving the life sciences industry. The deal was announced in July 2026.

What's the endgame? The acquisition is meant to strengthen Decera Clinical's position as a scientific activation partner to life sciences companies.

The signal: Private equity continues to consolidate specialist service providers around the life sciences sector, tucking knowledge platforms into larger clinical partners to broaden their offering.

Read more: PE Hub · The Riverside Company

Image credit: foteih (Openverse)